6533b85ffe1ef96bd12c2539

RESEARCH PRODUCT

The 2-oxoglutarate binding site of prolyl 4-hydroxylase. Identification of distinct subsites and evidence for 2-oxoglutarate decarboxylation in a ligand reaction at the enzyme-bound ferrous ion.

Kari MajamaaKari I. KivirikkoHartmut Hanauske-abelVolkmar Günzler

subject

chemistry.chemical_classificationCoordination sphereBinding SitesDecarboxylationStereochemistryIronProcollagen-Proline DioxygenaseChick EmbryoLigand (biochemistry)LigandsBiochemistryBinding CompetitiveDecarboxylationHydroxylationchemistry.chemical_compoundEnzymechemistryOxidoreductaseMoietyAnimalsKetoglutaric AcidsFerrous CompoundsBinding siteProtein Binding

description

The structure and function of the 2-oxoglutarate binding site of prolyl 4-hydroxylase was studied by assaying the inhibitory potential of 24 selected aliphatic or aromatic compounds. All except one of them inhibited the enzyme competitively with respect to 2-oxoglutarate and noncompetitively with respect to Fe2+, the Ki values ranging from 0.8 microM to over 15 mM. The Ki values for the two most effective inhibitors, pyridine 2,5-dicarboxylate and 2,4-dicarboxylate, were about 0.8 microM and 2 microM, these compounds being the most potent inhibitors of prolyl 4-hydroxylase with respect to 2-oxoglutarate known so far. Only one of the compounds tested, 2-oxoadipinate, was able to support hydroxylation by replacing 2-oxoglutarate as a cosubstrate. The data suggest that the 2-oxoglutarate binding site can be divided into three distinct subsites. Subsite I is probably a positively charged side chain of the enzyme that ionically binds the C5 carboxyl group of the 2-oxoglutarate, subsite II consists of two cis-positioned equatorial coordination sites of the enzyme-bound ferrous ion and is chelated by the C1-C2 moiety, while subsite III involves a hydrophobic binding site in the C3-C4 region of the cosubstrate. The sp3 rehybridization of C2 within the chelating moiety of the cosubstrate appears to be a crucial event during decarboxylation that proceeds in the form of a ligand reaction inside the Fe2+ coordination sphere.

10.1111/j.1432-1033.1984.tb07907.xhttps://pubmed.ncbi.nlm.nih.gov/6321169